GeneBio Systems
PRPS1/2/PRPS1L1 Polyclonal Antibody
PRPS1/2/PRPS1L1 Polyclonal Antibody
SKU:E-AB-15944
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Polyclonal Antibodies
Abbreviation: PRPS1/2/1L1
Target Synonym: ARTS;DFN2;PRSI;CMTX5;DFNX1;PRS-I;PPRibP/PRSII/PRPS1;PRPS3;PRPSL;PRS-III
Research Areas: Cancer;Cell Biology;Epigenetics and Nuclear Signaling;Metabolism
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human;Mouse
Application: WB;IHC
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: P60891,P11908,P21108
Accession:
Background: PRPS (phosphoribosyl pyrophosphate synthetase) proteins catalyze the synthesis of phosphoribosyl pyrophosphate (PRPP). Three human PRPS isoforms exist and are encoded by three different genes. PRPS1 and PRPS2 (also known as PRS1 and PRS2, respectively) are ubiquitously expressed, while PRPS3 (also known as PRPS1L1) is specific to the testis. PRPP is an important substrate synthesized from MgATP and ribose-5-phosphate in a reaction that requires inorganic phosphate and magnesium as a cofactor. PRPP is essential in the synthesis of nearly all nucleotides, implying that PRPS1/2 play an important role in nucleotide biosynthesis and purine metabolism. A mutation in the gene encoding PRPS1 may result in PRPS superactivity, a disease characterized by gout and the overproduction of purine nucleotides, uric acid and PRPP. PRPS1 mutations can also lead to a reduction in PRPS1 activity resulting in ARTS syndrome or CMTX5 (Charcot-Marie-Tooth disease X-linked recessive type 5).
Concentration: 0.4 mg/mL
Immunogen: Synthetic peptide of human PRPS1/2/1L1
Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification method: Affinity purification
Dilution: WB 1:500-1:2000;IHC 1:25-1:100
Calculated MW: 35kDa
ObservedMW:
